Related Experiment Video
Updated: Feb 5, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
A Patient Centricity Team Tool to Enable Patient-Focused Drug Development
Rebecca Ashkenazy1, Roslyn F Schneider2
11 US Medical Affairs, Women's and Men's Health Lead, Global Established Pharma, Pfizer Inc, New York, NY, USA.
Abstract:
In order to better understand and advance the field of patient-focused drug development, a multifunctional patient affairs team developed and piloted a Patient Centricity Team Tool (PCTT) within a large pharmaceutical organization. The tool is a computer-based survey designed to interrogate the frequency of team efforts in 20 areas of patient centricity across 4 dimensions: people, purpose, process, and actions. Results from a pilot with a Phase III product team indicate a spectrum of team activity of different frequencies related to patient-focused drug development. Given the lack of tool validation, interpretation of results remains a reflection of the team, asset, and lifecycle stage as opposed to a diagnostic of activities. Over time and with increased use across teams, tool implementation and associated learnings may yield organizational, product, and ultimately patient benefits.
More Related Videos
Related Concept Videos
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

